EP0383591A2 — Use of 5-methyl-1-phenyl-2-(1H)-pyridone in the prevention and treatment of fibrotic lesions
Assigned to Margolin Solomon B · Expires 1990-08-22 · 36y expired
What this patent protects
The composition comprising 5-methyl-1-phenyl-2-(1H)-pyridone is effective for the reparation and prevention of fibrotic lesions as in life-threatening asbestosis. 5-Methyl-1-phenyl-2-(1H)-pyridone exerts on the anti-fibrotic activity quite dissimilar to and independent of fibrino…
USPTO Abstract
The composition comprising 5-methyl-1-phenyl-2-(1H)-pyridone is effective for the reparation and prevention of fibrotic lesions as in life-threatening asbestosis. 5-Methyl-1-phenyl-2-(1H)-pyridone exerts on the anti-fibrotic activity quite dissimilar to and independent of fibrinolytic activity.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.